Ciliary dyskinesia is a genetic condition in which the tiny hair-like structures lining your airways, called cilia, don’t move properly. Because these cilia normally beat in coordinated waves to push mucus, bacteria, and debris out of your lungs, sinuses, and ears, their failure leads to chronic respiratory infections that start in infancy and persist throughout life. The condition is almost always referred to as primary ciliary dyskinesia (PCD), meaning it’s inherited rather than caused by damage from smoking or infection. Current estimates put PCD prevalence at roughly 1 in 7,500 people worldwide, though it has traditionally been quoted as 1 in 10,000 to 20,000 because many cases go undiagnosed.
How Cilia Work and What Goes Wrong
Healthy cilia are built around an internal skeleton of tiny protein tubes called microtubules. Attached to those tubes are motor proteins, known as dynein arms, that act like rowing engines. They use energy to make neighboring tubes slide against each other, which bends the cilium and creates a rhythmic, wave-like beating pattern. This coordinated motion is what drives the thin layer of mucus in your airways steadily upward toward your throat, where you swallow or cough it out.
In PCD, genetic mutations disrupt parts of this machinery. About 70% of people with PCD have visible structural defects in their cilia. The most common mutations affect the outer dynein arms, essentially knocking out the main motors. Without functioning motors, cilia either beat weakly, move in a stiff or disorganized pattern, or don’t move at all. The result is the same: mucus pools in the lungs, sinuses, and middle ear instead of being cleared, creating a breeding ground for repeated infections.
More than 50 genes have been linked to PCD. The two most frequently mutated are DNAH5 (responsible for 15% to 21% of all cases) and DNAI1 (2% to 10%). The condition follows an autosomal recessive inheritance pattern, meaning a child must inherit a defective copy of the same gene from both parents to develop the disease. Parents who each carry one copy typically have no symptoms themselves.
Symptoms From Birth Through Adulthood
PCD often announces itself within the first day or two of life. More than 80% of newborns with the condition develop respiratory distress shortly after birth, with rapid breathing, flaring nostrils, grunting, and sometimes a bluish tint to the skin. This happens because without working cilia, the fluid that fills a baby’s lungs before birth can’t be cleared efficiently, leading to mucus plugging and patches of collapsed lung tissue. Because this looks similar to other, more common causes of newborn breathing difficulty, PCD is frequently missed at this stage.
As infants grow, a daily wet cough and year-round nasal congestion become the hallmark symptoms. Nearly all children with PCD develop these early. Recurrent ear infections are extremely common and can lead to hearing problems, which in turn may delay speech development. Chronic sinusitis and nasal polyps are also typical. Over time, repeated lung infections (bronchitis and pneumonia) cause progressive damage to the airways, eventually leading to a condition called bronchiectasis, where the bronchial tubes become permanently widened and scarred.
Adults with PCD continue to deal with chronic cough, sinus disease, and recurrent infections. Lung function tends to decline slowly. Studies have reported annual drops in lung capacity of roughly 0.18% to 0.89% per year, though there is wide variation from person to person. Some individuals maintain relatively stable lung function for decades, while others progress more quickly. In severe cases, the median age at which lung transplant becomes a consideration is around 43.
Organs Beyond the Lungs
Cilia aren’t limited to the airways. They play roles throughout the body, which is why PCD can affect organ placement and fertility.
During embryonic development, specialized cilia in a structure called the node create a leftward flow of fluid that tells the body which side is which. When those cilia don’t work, organ placement becomes random. About 40% to 50% of people with PCD are born with their internal organs completely mirrored, a condition called situs inversus totalis, where the heart sits on the right side and the liver on the left. When PCD occurs together with situs inversus, it’s historically been called Kartagener syndrome. Situs inversus on its own usually doesn’t cause health problems, but it’s an important clue that can prompt earlier diagnosis of PCD.
Fertility is also affected. Sperm tails share the same internal structure as cilia, so men with PCD often have sperm that can’t swim effectively, leading to reduced fertility. In women, cilia line the fallopian tubes and uterus, where they help transport eggs and early embryos. Impaired ciliary motion in these areas can make natural conception more difficult, though many women with PCD do become pregnant, sometimes with assisted reproductive techniques.
How PCD Is Diagnosed
Diagnosis is notoriously difficult and often delayed. Many people aren’t identified until childhood or even adulthood, partly because the individual symptoms (wet cough, ear infections, sinus problems) are common in the general population. It’s the combination and persistence of these symptoms, starting in infancy and never fully resolving, that should raise suspicion.
Current guidelines from both the American Thoracic Society and the European Respiratory Society recommend a combination of tests rather than relying on any single one:
- Nasal nitric oxide measurement: People with PCD produce unusually low levels of nitric oxide in their nasal passages. A reading below roughly 77 nanoliters per minute is the widely used screening cutoff, though some experts recommend a higher threshold of about 108 nanoliters per minute to catch cases where cilia look structurally normal under a microscope. This test is simple and noninvasive, making it a good first step.
- High-speed video microscopy: A small brush is used to collect cells from inside the nose, and the cilia are filmed beating under a microscope at high frame rates. This is the only test that directly shows how living cilia move. Abnormal beat patterns, reduced frequency, or completely immotile cilia point toward PCD.
- Electron microscopy: A detailed look at the internal structure of cilia can reveal missing dynein arms, disorganized microtubules, or other defects. However, about 30% of PCD patients have cilia that look normal under electron microscopy despite being functionally abnormal.
- Genetic testing: Sequencing a panel of known PCD genes can confirm the diagnosis, especially in cases where other tests are inconclusive. The American Thoracic Society considers genetic testing a first-line diagnostic tool.
No single test catches every case. A positive result on any one of these is usually followed up with at least one more to build confidence in the diagnosis.
Daily Management
There is no cure for PCD, so treatment focuses on keeping the airways as clear as possible and treating infections early to slow lung damage. The cornerstone of daily care is airway clearance therapy. Chest physiotherapy, where specific techniques of percussion, vibration, or breathing exercises help loosen and move mucus out of the lungs, is considered standard. Sessions are typically done once or twice a day, and many people use handheld devices that create vibrations or positive pressure to assist the process. Studies comparing device-based techniques to traditional chest physiotherapy have found similar results for lung function, so the choice often comes down to personal preference and what a person will actually stick with long term.
Inhaling nebulized saline solutions before airway clearance can help thin mucus, making it easier to cough out. Regular physical exercise also promotes mucus clearance and maintains overall fitness, and many clinicians encourage it as part of the daily routine.
Infections are treated promptly with antibiotics, and some people with frequent flare-ups use long-term preventive antibiotics. Regular monitoring of lung function helps track disease progression and guides decisions about intensifying treatment. Ear tubes may be placed in children with chronic middle ear fluid to prevent hearing loss, and sinus surgery is sometimes needed for persistent sinus disease.
Long-Term Outlook
PCD is a lifelong condition, but its trajectory varies enormously. Some people maintain near-normal lung function well into middle age with consistent daily management, while others experience a steeper decline. Early diagnosis appears to make a meaningful difference, because starting airway clearance and infection control before significant lung damage accumulates gives the lungs a better starting point. The slow average rate of lung function decline, less than 1% per year in most studies, means that many people with PCD live full, active lives, though the daily treatment burden is real and ongoing. For the subset who do develop severe bronchiectasis, lung transplantation remains an option, typically considered when lung capacity drops to around 30% of predicted normal.